Crainio launches feasibility study supported by Innovate UK

April 2025

We’re excited to announce the start of our feasibility study, supported by an Innovate UK Biomedical Catalyst grant, to advance Crainio’s non-invasive intracranial hypertension measurement technology toward standard-of-care accuracy.

The study is being conducted in the Intensive Care Unit of The Royal London Hospital, led by Professor Chris Uff, Consultant Neurosurgeon.

This marks a major milestone as we work to make accurate, safe, and accessible brain pressure monitoring possible — without the need for invasive procedures.